Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-11T06:38:53.817Z Has data issue: false hasContentIssue false
  • English
  • Français

Intralesional triamcinolone acetonide injection in hypertrophic skin surrounding the percutaneous titanium implant of a bone-anchored hearing aid

Published online by Cambridge University Press:  05 February 2008

J B Van Rijswijk  and
E A M Mylanus
J B Van Rijswijk*
Affiliation:
Department of Otorhinolaryngology, Head & Neck Surgery and Facial Plastics, Van Weel-Bethesda Hospital, Dirksland, The Netherlands
E A M Mylanus
Affiliation:
Department of Otorhinolaryngology, Head & Neck Surgery, Radboud University Medical Center, Nijmegen, The Netherlands
*
Address for correspondence: Dr Jeroen B van Rijswijk, ENT Surgeon, Stationsweg 22, 3247 BW Dirksland, The Netherlands. Fax: +31 18760 7129 E-mail: jeroen@vanryswyk.nl
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We present a patient with persistent hypertrophic skin surrounding the percutaneous implant of a bone-anchored hearing aid system, successfully treated with intralesional applied corticosteroids.

Method:

Case report and review of the world literature concerning bone-anchored hearing aid implantation and intralesional applied corticosteroids for the treatment of hypertrophic scars and keloids.

Results:

Eight weeks after revision surgery to reduce surplus skin and subcutaneous scar tissue overgrowing the abutment, skin and subcutaneous scar tissue overgrowth reoccurred. As an alternative to yet another surgical procedure, the hypertrophic skin was treated with intralesional injections of triamcinolone acetonide. Three weeks after the treatment, a satisfying result was seen, and no subsequent relapse was observed.

Conclusion:

To our knowledge, this is the first, photographically well documented case report of a patient with persistent hypertrophic skin surrounding a percutaneous bone-anchored hearing aid implant, successfully treated with intralesional applied corticosteroids.

Keywords

Bone Anchored Hearing AidsImplants and ProsthesesIntralesional InjectionsTriamcinolone
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 122 , Issue 12 , December 2008 , pp. 1368 - 1370
Copyright
Copyright © JLO (1984) Limited 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Hol, MK, Spath, MA, Krabbe, PF, van der Pouw, CT, Snik, AF, Cremers, CW et al. The bone-anchored hearing aid: quality-of-life assessment. Arch Otolaryngol Head Neck Surg 2004;130:394–9CrossRefGoogle ScholarPubMed
2Tjellström, A, Håkansson, B. The bone-anchored hearing aid. Design principles, indications, and long-term clinical results. Otolaryngol Clin North Am 1995;28:53–72CrossRefGoogle ScholarPubMed
3Granström, G, Bergström, K, Odersjo, M, Tjellström, A. Osseointegrated implants in children: experience from our first 100 patients. Otolaryngol Head Neck Surg 2001;125:85–92CrossRefGoogle ScholarPubMed
4Shirazi, MA, Marzo, SJ, Leonetti, JP. Perioperative complications with the bone-anchored hearing aid. Otolaryngol Head Neck Surg 2006;134:236–9CrossRefGoogle ScholarPubMed
5van der Pouw, CT, Mylanus, EA, Cremers, CW. Percutaneous implants in the temporal bone for securing a bone conductor: surgical methods and results. Ann Otol Rhinol Laryngol 1999;108:532–6CrossRefGoogle ScholarPubMed
6Kunst, SJW, Leijendeckers, JM, Mylanus, EAM, Hol, MKS, Snik, AFM, Cremers, CWRJ. BAHA system application for unilateral congenital conductive hearing impairment: audiometric results. Unexpected good results in the unaided situation. Otol Neurotol 2008, in pressGoogle Scholar
7Wazen, JJ, Spitzer, J, Ghossaini, SN, Kacker, A, Zschommler, A. Results of the bone-anchored hearing aid in unilateral hearing loss. Laryngoscope 2001;111:955–8CrossRefGoogle ScholarPubMed
8Tjellström, A, Granström, G. How we do it: Frequency of skin necrosis after BAHA surgery. Clin Otolaryngol 2006;31:216–20CrossRefGoogle Scholar
9Lekakis, GK, Najuko, A, Gluckman, PG. Wound related complications following full thickness skin graft versus split thickness skin graft on patients with bone anchored hearing aids. Clin Otolaryngol 2005;30:324–7CrossRefGoogle ScholarPubMed
10Reddy, TN, Dutt, SN, Gangopadhyay, K. Modified incisions for reduction of soft tissue for one-stage, bone-anchored hearing aid implantation. Laryngoscope 2000;110:1584–5CrossRefGoogle ScholarPubMed
11Snyder, MC, Moore, GF, Johnson, PJ. The use of full-thickness skin grafts for the skin-abutment interface around bone-anchored hearing aids. Otol Neurotol 2003;24:255–8CrossRefGoogle ScholarPubMed
12Kiil, J. Keloids treated with topical injections of triamcinolone acetonide (Kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg 1977;11:169–72Google ScholarPubMed
13Muneuchi, G, Suzuki, S, Onodera, M, Ito, O, Hata, Y, Igawa, HH. Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg 2006;40:111–16CrossRefGoogle ScholarPubMed
14Krusche, T, Worret, WI. Mechanical properties of keloids in vivo during treatment with intralesional triamcinolone acetonide. Arch Dermatol Res 1995;287:289–93CrossRefGoogle ScholarPubMed
15Teelucksingh, S, Balkaran, B, Ganeshmoorthi, A, Arthur, P. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide. Ann Trop Paediatr 2002;22:89–91CrossRefGoogle ScholarPubMed